Riya Arun
About Riya Arun
Riya Arun is an Associate Scientist in QC Sample Management at Bristol Myers Squibb, with a background in Biology from the University of California, Santa Barbara.
Title
Riya Arun holds the position of Associate Scientist in QC Sample Management at Bristol Myers Squibb. In this role, Riya focuses on the cryo-preservation of peripheral blood mononuclear cells (PBMCs) and CAR-T therapies for Multiple Myeloma and Lymphoma patients. The work involves extensive oversight and quality assurance, ensuring the integrity of samples crucial for developing innovative treatments.
Company
Riya Arun is currently employed at Bristol Myers Squibb, working out of their facility in Summit, New Jersey, United States. Bristol Myers Squibb is a well-known biopharmaceutical company that focuses on researching and developing therapies for serious diseases. Riya's contributions play a vital role in advancing the company's mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
Previous Experience
Before joining Bristol Myers Squibb, Riya Arun worked as a Research Assistant at The Doyle Group in Santa Barbara, California. During this 9-month tenure from 2022 to 2023, Riya was involved in a dissertation project on cell differentiation and membrane potential. This role provided foundational experiences and skills that now contribute to her current responsibilities in sample management and quality control.
Education
Riya Arun earned a Bachelor of Science degree in Biological Sciences from the University of California, Santa Barbara (UCSB), where she studied from 2019 to 2023. During her time at UCSB, she gained expertise in several key areas, including cell differentiation and membrane potential. Riya also enhanced her skills in public speaking, team leadership, and event organization through peer mentoring and participation in student-run organizations.
Contributions and Responsibilities
At Bristol Myers Squibb, Riya Arun's responsibilities include the cryo-preservation of peripheral blood mononuclear cells (PBMCs) and CAR-T therapies, specifically for patients with Multiple Myeloma and Lymphoma. These duties are critical as they help in maintaining the quality and efficacy of treatments, especially for conditions with risky or invasive alternative treatments. Riya's role supports the development of therapies that aim for more effective and less invasive treatment options for serious illnesses.